期刊文献+

视神经脊髓炎谱系疾病的遗传学进展

Advances in the genetics of neuromyelitis optica spectrum disorders
下载PDF
导出
摘要 视神经脊髓炎谱系疾病(neuromyelitis optica spectrum disorders,NMOSD)是一种主要累及视神经和脊髓的中枢神经自身免疫疾病,自身免疫性水通道蛋白4(AQP4)的IgG抗体是其特异性抗体。人类主要组织相容性复合体(human leucocyte antigen,HLA)与多种疾病有关,尤其是自身免疫性疾病。目前认为不同国家、地区和种族,人类白细胞抗原基因多态性与视神经脊髓炎(NMO)的相关性有差异,不同人群的NMO相关基因多态性不同。对AQP4基因多态性与NMO的关系有所争议。多种细胞因子被认为与NMO相关,但其基因多态性与NMO的关系尚未明确,本文基于前期文献的综述,研究NMOSD的基因易感性。 Neuromyelitis optica spectrum disorders(NMOSD/NMO)is an autoimmune disorder that primarily affects the optic nerve and spinal cord.IgG antibodies against autoimmune aquaporin 4(AQP4)are its specific antibodies.Human leucocyte antigen(HLA)is related to a variety of diseases,especially autoimmune diseases.Currently,it is believed that the correlation between HLA gene polymorphism and NMO is different in different countries,regions and races.The NMO related gene polymorphism is different in different populations.The relationship between AQP4 gene polymorphism and NMO is controversial.Many cytokines are thought to be related to NMO.However,the relationship between gene polymorphism and NMO remains controversial.This article studies the genetic susceptibility to NMOSD based on reviews of previous literatures.
作者 何敏超 汪鸿浩 HE Min-chao;WANG Hong-hao(Guangzhou First People′s Hospital/The Second Affiliated Hospital,South China University of Technology,Guangzhou 510180,China)
出处 《实用医院临床杂志》 2023年第6期1-6,共6页 Practical Journal of Clinical Medicine
基金 国家自然科学基金资助项目(编号:82371364) 广东省自然科学基金资助项目(编号:2023A1515011372) 广州市医疗高新、重大、特色医疗项目(编号:2023C-TS31)。
关键词 视神经脊髓炎谱系疾病 抗水通道蛋白4IgG抗体 人类白细胞抗原 细胞因子 遗传学 Neuromyelitis optica spectrum disorders Aquaporin4-IgG Human leukocyte antigen Cytokine Genetics
  • 相关文献

参考文献8

二级参考文献41

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 2麦卫华,胡学强,陆正齐.AQP4基因多态性与多发性硬化及视神经脊髓炎遗传易感性关系的研究//中华医学会神经病学分会.中华医学会第十一届全国神经病学学术会议论文汇编,长春,2008.北京:中华医学会,2008:538.
  • 3Wingerchuk DM, Lennon VA, kucchinetti CF, et al. The spectrum of neuromyelitis optica [ J ]. Lancet Neuro1,2007,6 ( 9 ) : 805 - 815.
  • 4Lennon VA,Wingerchuk DM, Kryzer T J, et al. A serum autoantibody marker of neuromyelltis optiea:distinction from multiple sclerosis[J]. Lancet, 2004,364:2106 - 2112.
  • 5Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica[J]. Neurologist,2007,13 ( 1 ) : 2 - 11.
  • 6Vendrame M, Azizi SA. The spectrum of neuromyelitis optica : a case of NMO with extensive brain stem involvement[J]. Neurol Res,2007,29 (1) :32 -35.
  • 7Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel[ J ]. J Exp Med, 2005,202:473 - 477.
  • 8Wingerchuk DM, Lennon VA, Pittock SJ,et al. Revised diagnostic criteria for neuromyelitis optica [ J ]. Neurology, 2006,66 ( 10 ) : 1485 - 1489.
  • 9Okai AF, Muppidi S, Bagla R, et al. Progressive necrotizing myelopathy:part of the spectrum of neuromyelitis optica [J]. Neurol Res, 2006,28:354 - 359.
  • 10McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis [ J ]. Ann Neurol, 2001,50 ( 1 ) : 121 - 127.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部